You are here

Home

LYST THERAPEUTICS LLC

Company Information
Address
876 EBNER ST
COLUMBUS, OH 43206-2362
United States
Information

UEI: SKHMM6VSM8F3

# of Employees: 1
Ownership Information

HUBZone Owned: Yes

Socially and Economically Disadvantaged: No

Woman Owned: Unavailable

Award Charts




Award Listing

  • Record 1 TO 3

  1. Development of a LystaMab coated pericardial adhesion barrier

    Amount: $308,896.00

    SUMMARY Despite significant advances in the surgical and medical management of congenital heart disease, congenital cardiac anomalies remain a leading cause of death in the newborn period. Most severe ...

    SBIRPhase I2020Department of Health and Human Services National Institutes of Health

  2. LystaMab Immunotherapy to Inhibit Pericardial Adhesions

    Amount: $225,342.00

    SUMMARY Despite significant advances in the surgical and medical management of congenital heart diseasecongenital cardiac anomalies remain a leading cause of death in the newborn periodMost severe for ...

    STTRPhase I2019Department of Health and Human Services National Institutes of Health

  3. Targeted LystaMab Therapy to Optimize Tissue Engineered Vascular Graft Performance

    Amount: $222,703.00

    Project Description Despite significant advances in the surgical and medical management of congenital heart diseasecongenital cardiac anomalies remain a leading cause of death in the newborn periodMos ...

    STTRPhase I2018Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government